END-STAGE RENAL DISEASE (ESRD)
Clinical trials for END-STAGE RENAL DISEASE (ESRD) explained in plain language.
Never miss a new study
Get alerted when new END-STAGE RENAL DISEASE (ESRD) trials appear
Sign up with your email to follow new studies for END-STAGE RENAL DISEASE (ESRD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shorter dialysis? study tests if new method matches gold standard
Disease control Not yet recruitingThis study aims to find the best way to remove waste toxins from the blood of people with kidney failure who need dialysis. Researchers will compare a newer dialysis method at different treatment lengths against the current best method to see if they work equally well. The goal i…
Matched conditions: END-STAGE RENAL DISEASE (ESRD)
Phase: NA • Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New dialysis fluid aims to boost health for kidney patients
Disease control Not yet recruitingThis study is testing whether a special dialysis solution containing amino acids can improve the nutritional health of adults with end-stage kidney disease who use peritoneal dialysis. Researchers will compare participants' health before and after using the new solution daily for…
Matched conditions: END-STAGE RENAL DISEASE (ESRD)
Phase: PHASE4 • Sponsor: Shanghai 10th People's Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Hidden TB threat in dialysis patients under investigation
Knowledge-focused Not yet recruitingThis study aims to measure how common latent tuberculosis infection is among patients receiving regular kidney dialysis at Sohag University Hospital. Researchers will test 200 adult dialysis patients using a standard skin test to detect hidden TB infection. The goal is to underst…
Matched conditions: END-STAGE RENAL DISEASE (ESRD)
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:14 UTC